Bolt Biotherapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $11.7M | $7.2M | $10.8M | $9.2M | $27.4M | $5.5M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $30.3M | $50.8M | $105.7M | $172.7M | $189.2M | $25.4M |
| Property, Plant & Equipment | $1.2M | $3.1M | $5.0M | $6.5M | $6.2M | $4.1M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $56.7M | $99.6M | $159.8M | $227.8M | $307.7M | $46.5M |
| Liabilities | ||||||
| Accounts Payable | $1.4M | $1.5M | $3.0M | $3.6M | $3.6M | $1.6M |
| Total Current Liabilities | $8.4M | $15.9M | $20.5M | $23.1M | $21.3M | $11.3M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $30.2M | $42.4M | $47.0M | $56.3M | $57.6M | $46.2M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-460.8M | $-427.4M | $-364.3M | $-295.1M | $-207.0M | $-108.4M |
| Total Stockholders' Equity | $26.5M | $57.2M | $112.7M | $171.5M | $250.1M | $-104.9M |